{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:16:19Z","timestamp":1793459779591,"version":"4.5.0"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,8,15]]},"DOI":"10.2169\/internalmedicine.6650-20","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T22:06:22Z","timestamp":1615154782000},"page":"2601-2605","source":"Crossref","is-referenced-by-count":11,"title":["Ramucirumab-related Oral Pyogenic Granuloma: A Report of Two Cases"],"prefix":"10.2169","volume":"60","author":[{"given":"Tadanobu","family":"Aragaki","sequence":"first","affiliation":[{"name":"Section of Dentistry and Oral Surgery, Gunma Prefectural Cancer Center, Japan"},{"name":"Department of Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Tomomatsu","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Michi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology, Gunma Prefectural Cancer Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Fukai","sequence":"additional","affiliation":[{"name":"Section of Gastrointestinal Surgery, Gunma Prefectural Cancer Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Iijima","sequence":"additional","affiliation":[{"name":"Section of Pathology, Gunma Prefectural Cancer Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yoda","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jafarzadeh H, Sanatkhani M, Mohtasham N. Oral pyogenic granuloma: a review. J Oral Sci 48: 167-175, 2006.","DOI":"10.2334\/josnusd.48.167"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wollina U, Langner D, Franca K, Gianfaldoni S, Lotti T, Tchernev G. Pyogenic granuloma - a common benign vascular tumor with variable clinical presentation: new findings and treatment options. Open Access Maced J Med Sci 5: 423-426, 2017.","DOI":"10.3889\/oamjms.2017.111"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Harris MN, Desai R, Chuang TY, Hood AF, Mirowski GW. Lobular capillary hemangiomas: an epidemiologic report, with emphasis on cutaneous lesions. J Am Acad Dermatol 42: 423-426, 2000.","DOI":"10.1067\/mjd.2000.104520"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yuan K, Jin YT, Lin MT. The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry. J Periodontol 71: 701-706, 2000.","DOI":"10.1902\/jop.2000.71.5.701"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lim YH, Odell ID, Ko CJ, Choate KA. Somatic p.T771R KDR (VEGFR2) mutation arising in a sporadic angioma during ramucirumab therapy. JAMA Dermatol 151: 1240-1243, 2015.","DOI":"10.1001\/jamadermatol.2015.1925"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ibe T, Hamamoto Y, Takabatake M, Kamoshida S. Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment. BMJ Case Rep 12: e231464, 2019.","DOI":"10.1136\/bcr-2019-231464"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kosumi H, Nishie W, Sugai T, et al. Ramucirumab-induced multiple haemangiomas of the skin: two case reports. Acta Derm Venereol 98: 454-455, 2018.","DOI":"10.2340\/00015555-2869"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hironaka S. Anti-angiogenic therapies for gastric cancer. Asia Pac. J Clin Oncol 15: 208-217, 2019.","DOI":"10.1111\/ajco.13174"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Takahashi S. Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy. Biol Pharm Bull 34: 1785-1788, 2011.","DOI":"10.1248\/bpb.34.1785"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3: 391-400, 2004.","DOI":"10.1038\/nrd1381"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Spratlin JL, Mulder KE, Mackey JR. Ramucirumab (IMC-1121B): a novel attack on angiogenesis. Future Oncol 6: 1085-1094, 2010.","DOI":"10.2217\/fon.10.75"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Fuchs CS, Tomasek J, Yong CJ, et al; REGARD Trial Investigators. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 383: 31-39, 2014.","DOI":"10.1016\/S0140-6736(13)61719-5"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/16\/60_6650-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:38:06Z","timestamp":1715143086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/16\/60_6650-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,15]]},"references-count":12,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6650-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,15]]},"article-number":"6650-20"}}